Operating

Increase (Decrease) In Litigation Settlement Receivables

Roivant Sciences Increase (Decrease) In Litigation Settlement Receivables remained flat by 0.0% to $192.56M in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2025May 20, 2026

How to read this metric

An increase represents a positive cash inflow or the recognition of a future asset from legal proceedings, while a decrease reflects the collection of these funds.

Detailed definition

This tracks the change in receivables arising from legal settlements owed to the company. It represents the cash flow im...

Peer comparison

Highly variable across industries; common in firms involved in frequent intellectual property or commercial litigation.

Metric ID: operating_increase_decrease_in_litigation_settlement_rec_3da287

Historical Data

3 years
 FY'23FY'24FY'25
Value$0.00$0.00$770.24M
Range$0.00 – $770.24M

Increase (Decrease) In Litigation Settlement Receivables at Other Companies

Viatris logo
ViatrisVTRSView metric
Altria Group logo
Altria GroupMOView metric
McKesson logo
McKessonMCKView metric
Altria Group logo
Altria GroupMOView metric
Mastercard logo
MastercardMAView metric
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DDView metric

Frequently Asked Questions

What is Roivant Sciences's increase (decrease) in litigation settlement receivables?
Roivant Sciences (ROIV) reported increase (decrease) in litigation settlement receivables of $192.56M in Q1 2026.
What does increase (decrease) in litigation settlement receivables mean?
The change in money owed to the company from legal settlements.